STATE OF WISCONSIN CONTROLLED SUBSTANCES BOARD
IN THE MATTER OF RULE-MAKING : AFFIRMATIVE ACTION PROCEEDINGS BEFORE THE : ORDER OF THE CONTROLLED SUBSTANCES BOARD : CONTROLLED SUBSTANCES BOARD
FINDINGS
1. On October 6, 2020, the Department of Justice, Drug Enforcement Administration published an interim final rule in the Federal Register placing Remimazolam into schedule IV of the federal Controlled Substances Act. The scheduling action is effective October 6, 2020.
2. The Controlled Substances Board did not receive an objection to similarly treating Remimazolam as a schedule IV under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order designating Remimazolam as a controlled substance. 3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.19 and omitting the notice of proposed rule making, designating Remimazolam as a schedule IV controlled substance. ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats Remimazolam under chapter 961, Stats. by creating the following: CSB 2.79 Addition of Remimazolam to schedule IV. Section 961.20 (2) (mo), Stats., is created to read: 961.20 (2) (mo) Remimazolam
This order shall take effect on November 23, 2020 to allow for publication in the Administrative Register. The order expires upon promulgation of a final rule.
